The effect of warfarin sodium on excretion of calcium, phosphorus, and 4-carboxy-L-glutamic acid (Gla) was studied in 5 patients with ectopic calcification (2 with scleroderma, 1 with dermatomyositis, and 2 with myositis ossificans progressiva). Warfarin reduced urinary excretion of Gila in all patients, but no changes in calcium and phosphorus excretion or in objective parameters of calcinosis were observed during 6-36 months of treatment. Two patients experienced hemorrhagic complications during therapy, emphasizing a hazard of long-term anticoagulation treatment. Since ectopic calcium deposits contain Gla-rich protein, suppression of Gla synthesis by warfarin sodium over a longer ]period may prevent deposition and allow removal of existing calcinosis deposits. jEctopic calcification is an occasional complication of certain connective tissue diseases. It occurs rarely in systemic lupus erythematosus patients (l), in approximately 9% of patients with scleroderma (Z), and in 20% of adults and 40% of children with dermatomyositis (3). Muscle calcification also occurs in myositis ossificans (4), a relatively rare condition of unknown origin.